There
is significant interest in developing analytical methods
to characterize molecular recognition events between proteins and
phosphoinositides, which are a medically important class of carbohydrate-functionalized
lipids. Within this scope, one area of high priority involves quantitatively
evaluating drug candidates that pharmacologically inhibit protein–phosphoinositide
interactions. As full-length proteins are often difficult to produce,
establishing methods to study these interactions with shorter, bioactive
peptides would be advantageous. Herein, we report an atomic force
microscopy (AFM)-based force spectroscopic approach to detect the
specific interaction between an amphipathic, α-helical (AH)
peptide derived from the hepatitis C virus NS5A protein and its biological
target, the phosphatidylinositol (4,5)-bisphosphate [PI(4,5)P2] phosphoinositide receptor. After optimization of the peptide
tethering strategy and measurement parameters, the binding specificity
of AH peptide for PI(4,5)P2 receptors was comparatively
evaluated across a panel of phosphoinositides and the influence of
ionic strength on AH–PI(4,5)P2 binding strength
was tested. Importantly, these capabilities were translated into the
development of a novel experimental methodology to determine the inhibitory
activity of a small-molecule drug candidate acting against the AH–PI(4,5)P2 interaction, and extracted kinetic parameters agree well
with literature values obtained by conventional biochemical methods.
Taken together, our findings provide a nanomechanical basis for explaining
the high binding specificity of the NS5A AH to PI(4,5)P2 receptors, in turn establishing an analytical framework to study
phosphoinositide-binding viral peptides and proteins as well as a
broadly applicable approach to evaluate candidate inhibitors of protein–phosphoinositide
interactions.